Partial deletion of the long arm of chromosome 14 syndrome
par-shuhl dee-lee-shun of the lawng ahrm of kroh-muh-sohm fourteen sin-drohm
Also known as: Chromosome 14q deletion syndrome, 14q- syndrome
At a Glance
What is Partial deletion of the long arm of chromosome 14 syndrome?
Partial deletion of the long arm of chromosome 14 syndrome is a rare genetic condition caused by the loss of a segment of chromosome 14. This condition can affect multiple body systems, including the nervous, skeletal, and cardiovascular systems. It is typically caused by a spontaneous genetic mutation, meaning it often occurs without a family history. Over time, individuals may experience developmental delays, intellectual disabilities, and physical abnormalities. Early symptoms can include feeding difficulties and poor muscle tone, while later symptoms might involve speech delays and behavioral issues. Early diagnosis is critical to provide appropriate interventions and support. The condition can significantly impact family life, requiring ongoing care and support for the affected individual. Prognosis varies, but many individuals can lead fulfilling lives with the right support. Daily life may involve regular medical appointments, therapy sessions, and educational support. Families often benefit from connecting with support groups and resources. Genetic counseling is recommended for families to understand the condition and its implications. Management focuses on addressing symptoms and improving quality of life.
Medical Definition
Partial deletion of the long arm of chromosome 14 syndrome is characterized by the loss of genetic material from the distal region of chromosome 14q. Pathological mechanisms involve disrupted gene expression leading to developmental and functional abnormalities. Histological findings may reveal structural brain anomalies and other organ system defects. The condition is classified under chromosomal deletion syndromes and is considered rare, with an estimated prevalence of 1 in 50,000. The disease course is variable, with some individuals experiencing severe symptoms while others have milder manifestations. Management is symptomatic and supportive, focusing on enhancing development and quality of life.
Partial deletion of the long arm of chromosome 14 syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Developmental delay manifests as a significant lag in achieving milestones such as walking, talking, or social interaction. It is caused by the disruption of genes critical for neurodevelopment due to the chromosomal deletion. Over time, the delay may become more pronounced as peers continue to develop at a typical rate. This affects daily life by requiring additional educational support and therapies to aid in development.
Intellectual disability presents as difficulties in learning, reasoning, and problem-solving. The biological mechanism involves the loss of genetic material that is crucial for cognitive function. As the child grows, the gap in intellectual abilities compared to peers may widen. Daily life is impacted by the need for specialized educational programs and support to maximize learning potential.
Facial dysmorphism is characterized by distinct facial features such as a broad forehead, flat nasal bridge, or wide-set eyes. This occurs due to the deletion affecting genes responsible for craniofacial development. The features typically become more noticeable with age. While it does not directly impact health, it may affect social interactions and self-esteem, necessitating psychological support.
Common
Seizures manifest as sudden, uncontrolled electrical disturbances in the brain, leading to changes in behavior, movements, or consciousness. They are caused by the disruption of neural pathways due to the chromosomal deletion. The frequency and severity of seizures can vary, with some individuals experiencing them more frequently over time. Management includes antiepileptic medications and lifestyle adjustments to reduce triggers.
Hypotonia, or decreased muscle tone, presents as floppy muscles and joints, leading to difficulties with movement and posture. It results from the loss of genes that regulate muscle tone and neuromuscular function. Over time, hypotonia may improve with physical therapy, but some individuals may continue to experience challenges. Daily life is affected by the need for supportive devices and therapies to enhance mobility.
Behavioral issues can include hyperactivity, aggression, or difficulty with social interactions. These arise from the impact of the chromosomal deletion on brain regions involved in behavior regulation. Such issues may become more evident as the child interacts more with peers and the environment. Behavioral therapy and structured routines can help manage these challenges and improve social skills.
Less Common
Congenital heart defects may present as structural abnormalities in the heart, affecting its function. These defects occur due to the deletion impacting genes involved in cardiac development. The severity can range from mild to severe, potentially requiring surgical intervention. Regular cardiac monitoring and management are essential to ensure optimal heart function and quality of life.
Hearing loss can manifest as partial or complete inability to hear, affecting communication and language development. It is caused by the deletion affecting genes involved in auditory function. Over time, hearing loss may remain stable or progress, depending on the extent of genetic disruption. Hearing aids and speech therapy can significantly improve communication abilities and quality of life.
What Causes Partial deletion of the long arm of chromosome 14 syndrome?
Partial deletion of the long arm of chromosome 14, specifically involving the NRXN1 gene, is implicated in this syndrome. NRXN1 is located at 14q24.3 and encodes neurexin 1, a protein crucial for synaptic function. Mutations or deletions in NRXN1 disrupt the formation and maintenance of synapses by altering the protein's ability to interact with neuroligins. This disruption leads to impaired synaptic signaling and neurotransmitter release. Consequently, cellular communication within neural circuits is compromised, affecting brain function. The dysfunction of synaptic pathways can lead to altered neuronal excitability and network connectivity. Neuroinflammation may be triggered as a result of synaptic dysfunction, contributing to further neural damage. Degeneration of white matter structures can occur due to disrupted axonal transport and myelination. Symptoms manifest in a pattern reflecting the affected neural circuits, often involving cognitive and behavioral deficits. The variability in disease severity among patients may be due to the extent of the deletion and involvement of additional genes. Other genes on chromosome 14, if affected, might exacerbate or modify the phenotype. The immune response may also play a role in exacerbating neural damage. The interplay between genetic and environmental factors can influence the clinical presentation. Understanding the exact molecular mechanisms remains a challenge due to the complexity of genetic interactions. Research continues to explore potential therapeutic targets to mitigate synaptic dysfunction.
How is Partial deletion of the long arm of chromosome 14 syndrome Diagnosed?
Typical age of diagnosis: Partial deletion of the long arm of chromosome 14 syndrome is typically diagnosed in early childhood, often when developmental delays or other clinical symptoms prompt genetic evaluation. Diagnosis can occur prenatally if there is a known family history or if anomalies are detected during routine prenatal screening. Genetic counseling is crucial for families with a history of chromosomal abnormalities. Early diagnosis allows for timely intervention and management of symptoms.
Clinicians look for developmental delays, intellectual disabilities, and physical anomalies such as craniofacial dysmorphisms. A detailed family history is important to identify any hereditary patterns or previous diagnoses of chromosomal disorders. Physical examination may reveal hypotonia, growth retardation, or congenital malformations. This step helps to determine the need for further genetic testing and guides the clinician towards a possible chromosomal abnormality.
Magnetic Resonance Imaging (MRI) of the brain is commonly used to detect structural abnormalities. Specific findings may include cortical malformations or other brain anomalies associated with developmental delay. Imaging helps confirm the diagnosis by correlating clinical findings with structural changes. It also helps exclude other differential diagnoses such as isolated brain malformations or acquired brain injuries.
Standard blood tests are performed to rule out metabolic disorders that could mimic the symptoms. Biomarkers such as elevated lactate or ammonia levels may indicate metabolic conditions. Abnormal results prompt further metabolic or genetic testing to clarify the diagnosis. These tests help refine the diagnostic process and rule out other treatable conditions.
Chromosomal microarray analysis or whole exome sequencing is performed to identify deletions on chromosome 14. Deletions involving multiple genes can be detected, confirming the diagnosis of this syndrome. Results provide a definitive diagnosis and are crucial for genetic counseling. They also inform family planning decisions and help assess recurrence risk in future pregnancies.
Partial deletion of the long arm of chromosome 14 syndrome Treatment Options
Antiepileptic drugs (AEDs) are used to manage seizures, which are common in this syndrome. They work by stabilizing neuronal membranes and reducing excitability. Commonly used AEDs include valproic acid and levetiracetam. Clinical evidence supports their efficacy in reducing seizure frequency, although side effects such as drowsiness and gastrointestinal disturbances can occur. Long-term use requires regular monitoring of drug levels and liver function.
Techniques include motor skills training, balance exercises, and coordination activities. The goal is to improve functional abilities and enhance quality of life. Sessions are typically conducted 2-3 times per week, with duration adjusted based on individual progress. Measurable outcomes include improved gross and fine motor skills. Long-term benefits include increased independence and reduced risk of secondary complications.
Indicated for severe musculoskeletal deformities that impair function or cause pain. The procedure may involve tendon lengthening or joint stabilization. Expected benefits include improved mobility and pain relief. Surgical risks include infection and the need for repeat procedures. Post-operative care involves physical therapy to maintain surgical outcomes and improve function.
The team includes neurologists, geneticists, physical therapists, and psychologists. Interventions focus on optimizing developmental outcomes and managing comorbidities. Psychosocial support strategies involve counseling and support groups for families. Family education is provided on condition management and available resources. Long-term monitoring includes regular assessments to adjust care plans as needed.
When to See a Doctor for Partial deletion of the long arm of chromosome 14 syndrome
- Severe developmental delay — this may indicate significant neurological involvement requiring immediate evaluation.
- Unexplained seizures — could suggest underlying neurological complications that need urgent medical attention.
- Sudden loss of vision or hearing — may indicate acute neurological or sensory system involvement requiring emergency care.
- Progressive motor skill regression — may suggest worsening of the condition and should prompt a medical review.
- Persistent feeding difficulties — could lead to nutritional deficiencies and requires assessment by a healthcare provider.
- Frequent respiratory infections — may indicate compromised immune function or structural abnormalities needing medical evaluation.
- Mild developmental delays — monitor progress and consult with a pediatrician for developmental assessments.
- Occasional behavioral changes — observe for patterns and discuss with a healthcare provider if they persist or worsen.
Partial deletion of the long arm of chromosome 14 syndrome — Frequently Asked Questions
Is this condition hereditary?
Partial deletion of the long arm of chromosome 14 syndrome can be hereditary, often following an autosomal dominant pattern. The probability of passing the condition to children is 50% if one parent is affected. De novo mutations can occur, meaning the deletion may arise spontaneously without a family history. Carrier status can have implications for family planning, and genetic counseling is recommended to assess risks and options. Genetic counseling provides guidance on inheritance patterns and testing options.
What is the life expectancy for someone with this condition?
Life expectancy varies depending on the severity and age of onset of symptoms. Early intervention and management of complications can improve outcomes. Mortality is often related to complications such as respiratory infections or neurological issues. Treatment can enhance quality of life and potentially extend survival. Realistic expectations should include ongoing medical care and support for associated health challenges.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves genetic testing, often initiated after observing developmental delays or other clinical signs. The time from first symptoms to diagnosis can vary, often taking months to years. Specialists such as geneticists and neurologists are typically consulted. Delayed diagnosis may occur due to the rarity of the condition and nonspecific early symptoms. Confirmation is achieved through chromosomal analysis, such as array CGH or whole exome sequencing.
Are there any new treatments or clinical trials available?
Research is ongoing, with some promising studies focusing on gene therapy and targeted molecular treatments. Novel approaches aim to address specific genetic defects associated with the condition. ClinicalTrials.gov is a resource for finding relevant trials, and discussing options with a healthcare provider is advised. Patients should inquire about eligibility and potential benefits of participating in trials. New treatments may still be several years away from clinical application.
How does this condition affect daily life and activities?
The condition can impact mobility and self-care, requiring physical and occupational therapy. Educational challenges may arise, necessitating special education services and individualized learning plans. Social and emotional challenges include coping with developmental differences and potential isolation. Family burden can be significant, with caregivers needing support and respite. Supports such as adaptive equipment and community resources can greatly assist in daily living.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis.
Williams D, Onyia O, Chung DD et al. · Mol Vis · 2023 · PMID: 37287641
- 2.[Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays].
Wang L, Shi P, Ren H et al. · Zhonghua Yi Xue Yi Chuan Xue Za Zhi · 2022 · PMID: 36317203
- 3.Partial Deletion of Perk Improved High-Fat Diet-Induced Glucose Intolerance in Mice.
Lee J, Kim MJ, Moon S et al. · Endocrinol Metab (Seoul) · 2023 · PMID: 37956968
- 4.Partial deletion of DEPDC5 in a child with focal epilepsy.
Bonaglia MC, Giorda R, Epifanio R et al. · Epilepsia Open · 2016 · PMID: 29588938
- 5.Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function.
Nakatake M, Kurosaki H, Kuwano N et al. · Mol Ther Oncolytics · 2019 · PMID: 31236440
- 6.Partial Deletion of the Carboxyl-Terminal Signal Sequence of the Cellular Prion Protein Alters Protein Expression via Endoplasmic Reticulum-Associated Degradation.
Yoo M, Lee S, Kim J et al. · FASEB J · 2025 · PMID: 40906409
- 7.Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28.
Smets K, Deconinck T, Baets J et al. · Neurology · 2014 · PMID: 24814845
- 8.Normal sperm quality despite partial deletion of sY84 in the AZFa region: A case report.
Li D, Luo B, Luo Y et al. · Medicine (Baltimore) · 2024 · PMID: 39213242
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-16